ArticleCancers2023

Ibrutinib Inhibits BTK Signaling in Tumor-Infiltrated B Cells and Amplifies Antitumor Immunity by PD-1 Checkpoint Blockade for Metastatic Prostate Cancer.

Gengguo Deng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.